These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 312848)

  • 1. Study on the turnover of the receptor for the third component of complement on human lymphoid cells.
    Rosso di San Secondo VE; Meroni PL; Fortis C; Tedesco F
    J Immunol; 1979 May; 122(5):1658-62. PubMed ID: 312848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB; Lachmann PJ; Coombs RR
    Immunology; 1979 May; 37(1):25-34. PubMed ID: 112041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads.
    Huber Ch; Wigzell H
    Eur J Immunol; 1976 Jun; 5(6):432-5. PubMed ID: 1086242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of lymphocyte Fc alpha receptor in selective IgA deficiency and IgA nephropathy.
    Adachi M; Yodoi J; Masuda T; Takatsuki K; Uchino H
    J Immunol; 1983 Sep; 131(3):1246-51. PubMed ID: 6224855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of membrane-associated complement components (C 3 and C 4) on circulating human normal and leukemic leukocytes and on cultured cells with monkey erythrocytes.
    Burns GF; Cawley JC
    Eur J Immunol; 1979 Oct; 9(10):791-6. PubMed ID: 118035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV; Svehag SE; Leslie RG
    J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface properties of LDL-binding lymphocytes in human peripheral blood.
    Hiramatsu K; Sakai H; Endoh M; Arimori S
    Immunology; 1980 Mar; 39(3):311-6. PubMed ID: 6969214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
    Praz F; Lesavre P
    J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to block lymphocyte Fc receptor with anti-B lymphocyte sera (anti-DRW) in man.
    Soulillou JP; Peyrat MA
    Immunology; 1979 Mar; 36(3):519-25. PubMed ID: 312261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.
    Hyodo S; Kishi T; Kittaka E; Suzawa T; Tanabe A; Tanaka Y; Sakano T; Usui T
    Clin Exp Immunol; 1983 Jul; 53(1):140-4. PubMed ID: 6191894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans.
    Einstein LP; Hansen PJ; Ballow M; Davis AE; Davis JS; Alper CA; Rosen FS; Colten HR
    J Clin Invest; 1977 Nov; 60(5):963-9. PubMed ID: 332718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood.
    Ehlenberger AG; McWilliams M; Phillips-Quagliata JM; Lamm ME; Nussenzweig V
    J Clin Invest; 1976 Jan; 57(1):53-6. PubMed ID: 1081992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B; Dierich MP
    J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
    Lai A Fat RF; van Furth R
    Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro.
    Ueki A; Sai T; Oka H; Tabata M; Hosokawa K; Mochizuki Y
    Immunology; 1987 May; 61(1):11-4. PubMed ID: 3108140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.